CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.

Uehara K, Ikehara F, Tanabe Y, Nakazato I, Oshiro M, Inamine M, Kinjo T

Open source

DOI
10.1186/s13000-016-0468-4
Published
2016 Feb 1
Container
Diagnostic pathology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13000-016-0468-4,
  title = {CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.},
  author = {Uehara K and Ikehara F and Tanabe Y and Nakazato I and Oshiro M and Inamine M and Kinjo T},
  year = {2016},
  journal = {Diagnostic pathology},
  doi = {10.1186/s13000-016-0468-4},
  url = {https://doi.org/10.1186/s13000-016-0468-4}
}

RIS

TY  - JOUR
TI  - CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
AU  - Uehara K
AU  - Ikehara F
AU  - Tanabe Y
AU  - Nakazato I
AU  - Oshiro M
AU  - Inamine M
AU  - Kinjo T
PY  - 2016
JO  - Diagnostic pathology
DO  - 10.1186/s13000-016-0468-4
UR  - https://doi.org/10.1186/s13000-016-0468-4
ER  - 

APA

K, U., F, I., Y, T., I, N., M, O., M, I., & T, K. (2016). CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.. Diagnostic pathology. https://doi.org/10.1186/s13000-016-0468-4

Source records